PubMed

Rosiglitazone reduces glucose-stimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin-resistant individuals.

Kim SH, Abbasi F, Chu JW, McLaughlin TL, Lamendola C, Polonsky KS, Reaven GM.

Diabetes. 2005 Aug;54(8):2447-52.PMID: 16046313 [PubMed - indexed for MEDLINE]Related articlesFree article

Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals.

Jones CN, Pei D, Staris P, Polonsky KS, Chen YD, Reaven GM.

J Clin Endocrinol Metab. 1997 Jun;82(6):1834-8.PMID: 9177392 [PubMed - indexed for MEDLINE]Related articlesFree article

Rosiglitazone improves insulin sensitivity and glucose tolerance in subjects with impaired glucose tolerance.

Hung YJ, Hsieh CH, Pei D, Kuo SW, Lee JT, Wu LY, He CT, Lee CH, Fan SC, Sheu WH.

Clin Endocrinol (Oxf). 2005 Jan;62(1):85-91.PMID: 15638875 [PubMed - indexed for MEDLINE]Related articles

Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone.

Osei K, Gaillard T, Schuster D.

Metabolism. 2007 Jan;56(1):24-9.PMID: 17161222 [PubMed - indexed for MEDLINE]Related articles

Longitudinal changes in pancreatic beta-cell function and metabolic clearance rate of insulin in pregnant women with normal and abnormal glucose tolerance.

Catalano PM, Drago NM, Amini SB.

Diabetes Care. 1998 Mar;21(3):403-8. Erratum in: Diabetes Care 1999 Jun;22(6):1013. PMID: 9540023 [PubMed - indexed for MEDLINE]Related articlesFree article

[Primary study on characteristics of insulin secretion rate, metabolic clearance rate and sensitivity in non-insulin-dependent diabetic subjects from multiplex diabetic pedigrees]

Ran J, Cheng H, Li F.

Zhonghua Yi Xue Za Zhi. 2000 Jan;80(1):38-41. Chinese. PMID: 11798736 [PubMed - indexed for MEDLINE]Related articles

Relationship between changes in insulin sensitivity and associated cardiovascular disease risk factors in thiazolidinedione-treated, insulin-resistant, nondiabetic individuals: pioglitazone versus rosiglitazone.

Abbasi F, Lima NK, Reaven GM.

Metabolism. 2009 Mar;58(3):373-8.PMID: 19217454 [PubMed - indexed for MEDLINE]Related articles

Short administration of metformin improves insulin sensitivity in android obese subjects with impaired glucose tolerance.

Scheen AJ, Letiexhe MR, Lefèbvre PJ.

Diabet Med. 1995 Nov;12(11):985-9.PMID: 8582131 [PubMed - indexed for MEDLINE]Related articles

Roles of insulin resistance and obesity in regulation of plasma insulin concentrations.

Jones CN, Abbasi F, Carantoni M, Polonsky KS, Reaven GM.

Am J Physiol Endocrinol Metab. 2000 Mar;278(3):E501-8.PMID: 10710505 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma leptin levels, insulin secretion, clearance and action on glucose metabolism in anorexia nervosa.

Letiexhe MR, Scheen AJ, Lefèbvre PJ.

Eat Weight Disord. 1997 Jun;2(2):79-86.PMID: 14655846 [PubMed - indexed for MEDLINE]Related articles

Insulin secretion and clearance during low-dose graded glucose infusion.

Byrne MM, Sturis J, Polonsky KS.

Am J Physiol. 1995 Jan;268(1 Pt 1):E21-7.PMID: 7840177 [PubMed - indexed for MEDLINE]Related articles

Insulin secretion, clearance and action before and after gastroplasty in severely obese subjects.

Letiexhe MR, Scheen AJ, Gérard PL, Desaive C, Lefèbvre PJ.

Int J Obes Relat Metab Disord. 1994 May;18(5):295-300.PMID: 8061722 [PubMed - indexed for MEDLINE]Related articles

Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.

Hung YJ, Lin SH, Pei D, Kuo SW, Hsieh CH, He CT, Hsing Lee C, Fan SC, Sheu WH.

Metabolism. 2006 Apr;55(4):439-44.PMID: 16546473 [PubMed - indexed for MEDLINE]Related articles

Development of hyperinsulinemia and insulin resistance during the early stage of weight gain.

Erdmann J, Kallabis B, Oppel U, Sypchenko O, Wagenpfeil S, Schusdziarra V.

Am J Physiol Endocrinol Metab. 2008 Mar;294(3):E568-75. Epub 2008 Jan 2.PMID: 18171910 [PubMed - indexed for MEDLINE]Related articlesFree article

Fluid retention and vascular effects of rosiglitazone in obese, insulin-resistant, nondiabetic subjects.

Rennings AJ, Smits P, Stewart MW, Tack CJ.

Diabetes Care. 2006 Mar;29(3):581-7.PMID: 16505510 [PubMed - indexed for MEDLINE]Related articlesFree article

Discrepancies in the regulation of plasma adiponectin and TNF-alpha levels and adipose tissue gene expression in obese African Americans with glucose intolerance: a pilot study using rosiglitazone.

Osei K, Gaillard T, Cook C, Kaplow J, Bullock M, Schuster D.

Ethn Dis. 2005 Autumn;15(4):641-8.PMID: 16259488 [PubMed - indexed for MEDLINE]Related articles

Low-dose rosiglitazone exerts an antiinflammatory effect with an increase in adiponectin independently of free fatty acid fall and insulin sensitization in obese type 2 diabetics.

Ghanim H, Dhindsa S, Aljada A, Chaudhuri A, Viswanathan P, Dandona P.

J Clin Endocrinol Metab. 2006 Sep;91(9):3553-8. Epub 2006 Jun 27.PMID: 16804037 [PubMed - indexed for MEDLINE]Related articlesFree article

Dose-dependent effects of oral and intravenous glucose on insulin secretion and clearance in normal humans.

Tillil H, Shapiro ET, Miller MA, Karrison T, Frank BH, Galloway JA, Rubenstein AH, Polonsky KS.

Am J Physiol. 1988 Mar;254(3 Pt 1):E349-57.PMID: 3279811 [PubMed - indexed for MEDLINE]Related articles

The metabolic clearance of insulin and the feedback inhibition of insulin secretion are altered with aging.

Fink RI, Revers RR, Kolterman OG, Olefsky JM.

Diabetes. 1985 Mar;34(3):275-80.PMID: 3882495 [PubMed - indexed for MEDLINE]Related articles

Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.

Triplitt C, Glass L, Miyazaki Y, Wajcberg E, Gastaldelli A, De Filippis E, Cersosimo E, DeFronzo RA.

Diabetes Care. 2006 Nov;29(11):2371-7.PMID: 17065670 [PubMed - indexed for MEDLINE]Related articlesFree article